title: [Molecular targeted therapies and cytotoxics: Friends or foes?].
authors.affiliation: Service d'oncologie et hématologie, site Louis Pasteur, Hôpitaux de Chartres 4, rue Claude Bernard, 28630 Chartres-Le Coudray cedex, France. Electronic address: svignot@ch-chartres.fr.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Vignot
authors.affiliation: Service de pneumologie et oncologie thoracique, Université de Caen-Basse Normandie, Hôpital de la Côte-de-Nacre, 14033 Caen CS 3001, France.
authors.forename: Gérard
authors.initials: G
authors.lastname: Zalcman
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D000077156:Gefitinib; D018773:Genes, erbB-1; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D058990:Molecular Targeted Therapy / Q000379:methods*; D011799:Quinazolines / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib